TNFSF4 and neoplasm: In some studies, the combination of recombinant costimulatory ligand proteins (OX40L/4-1BBL) with tumor-associated antigens [19], virus-based vaccines [20], and tumor lysate vaccines [21] have been generating antitumor activities in some mouse models.